Atrion Corporation

Equities

ATRI

US0499041053

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 28/05/2024 BST 5-day change 1st Jan Change
456 USD -1.49% Intraday chart for Atrion Corporation +1.06% +20.40%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Nordson to Acquire Atrion for $460 Per Share in Cash MT
Transcript : Atrion Corporation, Nordson Corporation - M&A Call
Nordson to Buy Atrion for $460 per Share MT
Nordson to Buy Atrion for $460 per Share MT
Nordson Medical Corporation entered into an agreement to acquire Atrion Corporation for approximately $820 million. CI
Atrion Keeps Quarterly Cash Dividend at $2.20 a Share, Payable June 28 to Holders of Record June 14 MT
Atrion Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $47.3M MT
Atrion Corporation Provides Production Guidance for the Third Quarter of 2024 CI
Atrion Corporation Announces Not Stand for Re-Election of Hugh J. Morgan, Jr. as Member of Board CI
Atrion Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (ATRI) ATRION CORPORATION Reports Q4 Revenue $43.6M MT
Earnings Flash (ATRI) ATRION CORPORATION Posts Q4 EPS $3.65 MT
Atrion Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Atrion Keeps Quarterly Cash Dividend at $2.20 Per Share, Payable on March 29 to Shareholders of Record on March 15 MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on March 29, 2024 CI
North American Morning Briefing : S&P 500 Futures Ease From Nvidia-Inspired Record High DJ
Atrion Corporation Enters into an Amended and Restated Credit Agreement CI
Atrion Maintains Quarterly Dividend at $2.20 a Share, Payable Dec. 15 to Shareholders of Record on Dec. 1 MT
Atrion Corporation Declares Quarterly Cash Dividend, Payable on December 15, 2023 CI
Tranche Update on Atrion Corporation's Equity Buyback Plan announced on May 22, 2015. CI
Atrion Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (ATRI) ATRION CORPORATION Posts Q3 Revenue $41.9M MT
Atrion Corporation Announces Election of Jeannette Bankes as Director CI
Atrion Increases Dividend to $2.20 a Share From $2.15, Payable on Sept. 29 to Shareholders as of Sept. 15 MT
Chart Atrion Corporation
More charts
Atrion Corporation develops and manufactures products, primarily for medical applications. The Company's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. It has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The Company also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Related indices
More about the company
  1. Stock Market
  2. Equities
  3. ATRI Stock
  4. News Atrion Corporation
  5. Earnings Flash (ATRI) ATRION CORPORATION Posts Q1 Revenue $47.3M